Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥2,335 JPY
Change Today -20.50 / -0.87%
Volume 3.9M
4568 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
Frankfurt
As of 2:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daiichi sankyo co ltd (4568)

Year over year, Daiichi Sankyo Company, Limited has been able to grow their bottom line from ¥60.9B JPY to ¥322.1B JPY despite declining revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2012
Restated
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
Mar 31
2015
Press
Release

JPY
4 Year
Trend
Revenues938,677.0997,852.01,118,241.0919,372.0
TOTAL REVENUES938,677.0997,852.01,118,241.0919,372.0
Cost of Goods Sold268,609.0313,657.0402,289.0323,087.0
GROSS PROFIT670,068.0684,195.0715,952.0596,285.0
Selling General & Admin Expenses, Total386,811.0400,631.0413,187.0331,195.0
R&D Expenses185,052.0183,047.0191,212.0190,666.0
OTHER OPERATING EXPENSES, TOTAL571,863.0583,678.0604,399.0521,861.0
OPERATING INCOME98,205.0100,517.0111,553.074,424.0
Interest Expense-3,712.0-4,220.0---3,160.0
Interest and Investment Income5,514.06,918.05,732.09,600.0
NET INTEREST EXPENSE1,802.02,698.05,732.06,440.0
Income (Loss) on Equity Investments-207.0-397.0-1,426.0-925.0
Currency Exchange Gains (Loss)-8,046.0-11,735.0----
Other Non-Operating Income (Expenses)-15,540.01,652.0-16,084.0-2.0
EBT, EXCLUDING UNUSUAL ITEMS76,214.092,735.099,775.079,937.0
Merger & Restructuring Charges-1,279.0------
Gain (Loss) on Sale of Investments4,392.05,815.0----
Gain (Loss) on Sale of Assets5,376.01,976.0----
Other Unusual Items, Total-50,788.0-8,432.0----
Other Unusual Items-41,394.0-5,383.0----
EBT, INCLUDING UNUSUAL ITEMS33,915.092,094.099,775.079,937.0
Income Tax Expense39,757.023,900.046,417.036,370.0
Minority Interest in Earnings16,225.0-1,573.07,585.03,195.0
Earnings from Continuing Operations-5,842.068,194.053,358.043,567.0
EARNINGS FROM DISCOUNTINUED OPERATIONS------275,357.0
NET INCOME10,383.066,621.060,943.0322,119.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS10,383.066,621.060,943.0322,119.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS10,383.066,621.060,943.046,762.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4568:JP ¥2,335.00 JPY -20.50

4568 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Array BioPharma Inc $7.52 USD +0.14
BioCryst Pharmaceuticals Inc $11.42 USD +0.12
BioMerieux €103.75 EUR +4.08
Infinity Pharmaceuticals Inc $12.85 USD -0.02
Ipsen SA €51.16 EUR +0.13
View Industry Companies
 

Industry Analysis

4568

Industry Average

Valuation 4568 Industry Range
Price/Earnings 35.0x
Price/Sales 1.8x
Price/Book 1.3x
Price/Cash Flow 5.1x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAIICHI SANKYO CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.